Clinical Trials Logo
  1. Home
  2. Cancer of Lung
  3. NCT02853188

Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung — FT-KBP  

Cancer of Lung Clinical Trial

Official title:
Does the Measure of the Plasma Tissue Factor Allow to Predict a Venous Thromboembolism Episode for Patients Presenting a Primitive Lung Cancer?

Clinical Trial Summary

The aim of the study is to evaluate if the plasma activity of the tissue factor at the time of the diagnosis of a lung cancer, before any treatment, or after the treatment of induction (surgery or two first cures of chemotherapy), can be a predictive factor of venous thromboembolism disease in the year which follows the diagnosis, independently of the other parameters.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02853188
Study type Interventional
Source Hopital Foch
Contact
Status Completed
Phase N/A
Start date December 4, 2014
Completion date December 20, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT01860898 - A Phase I Study of iPS Cell Generation From Patients With COPD N/A
Completed NCT05011890 - Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® N/A
Active, not recruiting NCT02931942 - Changing Over Time of Ascorbic Acid After Chemotherapy
Completed NCT02616211 - An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
Active, not recruiting NCT04300244 - Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma Phase 2
Enrolling by invitation NCT05844761 - Real-time Motion Management During Prostate and Lung Radiotherapy N/A
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Terminated NCT02673021 - MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) N/A
Terminated NCT03603652 - NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung N/A
Not yet recruiting NCT05857995 - Precision Lung Cancer Survivorship Care Intervention N/A
Completed NCT03102229 - Real-time Activity Monitoring to Prevent Admissions During RadioTherapy N/A
Recruiting NCT04699188 - Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation Phase 1/Phase 2
Completed NCT02410603 - Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
Completed NCT00328588 - LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy Phase 2
Recruiting NCT02549638 - Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
Completed NCT02370303 - A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
Completed NCT01470248 - Study of Arsenic Trioxide in Small Cell Lung Cancer Phase 2
Recruiting NCT04717804 - 4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients N/A
Recruiting NCT04263467 - High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM) N/A
Not yet recruiting NCT06258954 - Effect of 3D-printed Reconstruction System in Size of Left DLT N/A